These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18205831)

  • 1. Amyloid-cholinesterase interactions. Implications for Alzheimer's disease.
    Inestrosa NC; Dinamarca MC; Alvarez A
    FEBS J; 2008 Feb; 275(4):625-32. PubMed ID: 18205831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils.
    Alvarez A; Opazo C; Alarcón R; Garrido J; Inestrosa NC
    J Mol Biol; 1997 Sep; 272(3):348-61. PubMed ID: 9325095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush.
    Rosini M; Simoni E; Bartolini M; Cavalli A; Ceccarini L; Pascu N; McClymont DW; Tarozzi A; Bolognesi ML; Minarini A; Tumiatti V; Andrisano V; Mellor IR; Melchiorre C
    J Med Chem; 2008 Aug; 51(15):4381-4. PubMed ID: 18605718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abeta-globulomers are formed independently of the fibril pathway.
    Gellermann GP; Byrnes H; Striebinger A; Ullrich K; Mueller R; Hillen H; Barghorn S
    Neurobiol Dis; 2008 May; 30(2):212-20. PubMed ID: 18353662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholinesterase interaction with Alzheimer amyloid beta.
    Inestrosa NC; Sagal JP; Colombres M
    Subcell Biochem; 2005; 38():299-317. PubMed ID: 15709485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid membrane templates the ordering and induces the fibrillogenesis of Alzheimer's disease amyloid-beta peptide.
    Chi EY; Ege C; Winans A; Majewski J; Wu G; Kjaer K; Lee KY
    Proteins; 2008 Jul; 72(1):1-24. PubMed ID: 18186465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholinesterase as an amyloid enhancing factor in PrP82-146 aggregation process.
    Pera M; Martínez-Otero A; Colombo L; Salmona M; Ruiz-Molina D; Badia A; Clos MV
    Mol Cell Neurosci; 2009 Feb; 40(2):217-24. PubMed ID: 19038345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of acetylcholinesterase peripheral anionic site ligands through computational refinement of a directed library.
    Dickerson TJ; Beuscher AE; Rogers CJ; Hixon MS; Yamamoto N; Xu Y; Olson AJ; Janda KD
    Biochemistry; 2005 Nov; 44(45):14845-53. PubMed ID: 16274232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
    Pákáski M; Kálmán J
    Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptide hairpin inhibitor of amyloid beta-protein oligomerization and fibrillogenesis.
    Yamin G; Ruchala P; Teplow DB
    Biochemistry; 2009 Dec; 48(48):11329-31. PubMed ID: 19877710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of acetylcholinesterase (AChE) from beta-amyloid plaques assemblies improves the spatial memory impairments in APP-transgenic mice.
    Dinamarca MC; Arrázola M; Toledo E; Cerpa WF; Hancke J; Inestrosa NC
    Chem Biol Interact; 2008 Sep; 175(1-3):142-9. PubMed ID: 18599028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure.
    Hirohata M; Hasegawa K; Tsutsumi-Yasuhara S; Ohhashi Y; Ookoshi T; Ono K; Yamada M; Naiki H
    Biochemistry; 2007 Feb; 46(7):1888-99. PubMed ID: 17253770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gorge-spanning, high-affinity cholinesterase inhibitor to explore beta-amyloid plaques.
    Elsinghorst PW; Härtig W; Goldhammer S; Grosche J; Gütschow M
    Org Biomol Chem; 2009 Oct; 7(19):3940-6. PubMed ID: 19763296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzofuran-based hybrid compounds for the inhibition of cholinesterase activity, beta amyloid aggregation, and abeta neurotoxicity.
    Rizzo S; Rivière C; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Morroni F; Tarozzi A; Monti JP; Rampa A
    J Med Chem; 2008 May; 51(10):2883-6. PubMed ID: 18419109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinesterase inhibitors: xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation.
    Belluti F; Rampa A; Piazzi L; Bisi A; Gobbi S; Bartolini M; Andrisano V; Cavalli A; Recanatini M; Valenti P
    J Med Chem; 2005 Jun; 48(13):4444-56. PubMed ID: 15974596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterases in the amyloid angiopathy of Alzheimer's disease.
    Mesulam M; Carson K; Price B; Geula C
    Ann Neurol; 1992 May; 31(5):565-9. PubMed ID: 1375822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
    Carver JA; Duggan PJ; Ecroyd H; Liu Y; Meyer AG; Tranberg CE
    Bioorg Med Chem; 2010 Jan; 18(1):222-8. PubMed ID: 19931462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of zinc(II) and copper(II) to the full-length Alzheimer's amyloid-beta peptide.
    Tõugu V; Karafin A; Palumaa P
    J Neurochem; 2008 Mar; 104(5):1249-59. PubMed ID: 18289347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.